Salivary analysis of drugs - Potential and difficulties

Analytical Letters

Volumn 41, Issue 6, 2008, Pages 925-948

  Townsend, S ^a   Fanning, L ^a   O'Kennedy, R ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Illicit drug detection; Immunoassay; Saliva; Sample collection

Indexed keywords

EID: 45849084292     PISSN: 00032719     EISSN: 1532236X     Source Type: Journal    
DOI: 10.1080/00032710802053815     Document Type: Short Survey

References (46)

1. Aps, J.K.M. and Martens, L.C. 2005. Review: The physiology of saliva and transfer of drugs into saliva. Forensic Sci. Int., 150: 119-131.
2. Barrett, C., Good, C., and Moore, C. 2001. Comparison of point-of-collection screening of drugs of abuse in oral fluid with a laboratory-based urine screen. Forensic Sci. Int., 122: 163-166.
3. Beckett, A.H., Rowland, M., and Turner, P. 1965. Influence of urinary pH on excretion of amphetamine. Lancet, 1: 303.
4. Bennett, G.A., Davies, E., and Thomas, P. 2003. Is oral fluid analysis as accurate as urinalysis in detecting drug use in a treatment setting? Drug Alcoh. Depend., 72: 265-269.
5. Biermann, T., Schwarze, B., Zedler, B., and Betz, P. 2004. On-site testing of illicit drugs: The use of the drug-testing device "Toxiquick®." Forensic Sci. Int., 143: 21-25.
6. Braithwaite, R.A., Jarvie, D.R., Minty, P.S., Simpson, D., and Widdop, B. 1995. Screening for drugs of abuse. I: Opiates, amphetamines and cocaine. Ann. Clin. Biochem., 32: 123-153.
7. Brennan, J., Dillon, P., and O'Kennedy, R. 2003. Production, purification and characterisation of genetically derived scFv and bifunctional antibody fragments capable of detecting illicit drug residues. J. Chromatogr. B. Anal. Technol. Biomed. Life. Sci., 786: 327-342.
8. Caddy, B. 1984. Saliva as a specimen for drug analysis. Advanc. Anal. Toxicol., 1: 198-254.
9. Chiappin, S., Antonelli, G., Gatti, R., and De Palo, E.F. 2007. Saliva specimen: A new laboratory tool for diagnostic and basic investigation. Clin. Chim. Acta., 383 (1-2): 30-40.
10. Cone, E.J., Darwin, W.D., and Wang, W.L. 1993. The occurrence of cocaine, heroin and metabolites in hair of drug abusers. Forensic Sci. Int., 63: 55-68.
11. Cone, E.J., Presley, L., Lehrer, M. 2002. Oral fluid testing for drugs of abuse: Positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J. Anal. Toxicol., 26: 541-546.
12. Connell, J.A., Parry, J.V., Mortimer, P.P., and Duncan, J. 1993. Novel assay for the detection of immunoglobulin G antihuman immunodeficiency virus in untreated saliva and urine. J. Med. Virol., 41: 159-164.
13. Cooper, T.B., Bark, N., and Simpson, G.M. 1981. Prediction of steady state plasma and saliva levels of desmethylimipramine using a single dose, single time point procedure. Psychopharmacology (Berl)., 74: 115-121.
14. Crouch, D.J. 2005. Oral fluid collection: The neglected variable in oral fluid testing. Forensic Sci. Int., 150: 165-173.
15. Dillon, P., Manning, B., Daly, S., Killard, A., and O'Kennedy, R. 2003. Production of a recombinant anti-morphine-3-glucuronide single-chain variable fragment (scFv) antibody for the development of a "real-time" biosensor-based immunoassay. J. Immunol. Meth., 276: 151-161.
16. Elliott, C.T., Baxter, G.A., and Hewitt, S.A. 1998. Use of biosensors for rapid drug residue analysis without sample deconjugation or clean-up: A possible way forward. Analyst, 123: 2469-2473.
17. Fucci, N., De Giovanni, N., and Chiarotti, M. 2003. Simultaneous detection of some drugs of abuse in saliva samples by SPME technique. Forensic Sci. Int., 134: 40-45.
18. Gross, J., Johnson, J., Sigler, L., and Stitzer, M.L. 1995. Dose effects of nicotine gum. Addict. Behav., 20: 371-381.
19. Haeckel, R. and Hanecke, P. 1996. Application of saliva for drug monitoring. An in vivo model for transmembrane transport. Eur. J. Clin. Chem. Clin. Biochem., 34: 171-191.
20. Hofman, L.F. 2001. Human saliva as a diagnostic specimen. J. Nutr., 131: 1621S-1625S.
21. Hold, K.M., de Boer, D., Zuidema, J., and Maes, R.A. 1995. Evaluation of the Salivette as sampling device for monitoring beta-adrenoceptor blocking drugs in saliva. J. Chromatogr. B. Biomed. Appl., 663: 103-110.
22. Huestis, M.A. and Cone, E.J. 2004. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J. Anal. Toxicol., 28: 394-399.
23. Jenkins, A.J., Oyler, J.M., and Cone, E.J. 1995. Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J. Anal. Toxicol., 19: 359-374.
24. Kacinko, S.L., Barnes, A.J., and Kim, I. 2004. Performance characteristics of the Cozart® RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Sci. Int., 141: 41-48.
25. Kadehjian, L. 2005. Legal issues in oral fluid testing. Forensic Sci. Int., 150: 151-160.
26. Kato, K., Hillsgrove, M., Weinhold, L., Gorelick, D.A., Darwin, W.D., and Cone, E.J. 1993. Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions. J. Anal. Toxicol., 17: 338-341.
27. Kintz, P. and Samyn, N. 1999. Determination of "Ecstasy" components in alternative biological specimens. J. Chromatogr. B. Biomed. Appl., 733: 137-143.
28. Lu, H., Kreuzer, M., Takkinen, K., and Guilbault, G. 2007. A recombinant Fab fragment-based electrochemical immunosensor for the determination of testosterone in bovine urine. Biosens. Bioelec., 22: 1756-1763.
29. Moore, L., Wicks, J., Spiehler, V., and Holgate, R. 2001. Gas chromatography-mass spectrometry confirmation of Cozart RapiScan saliva methadone and opiates tests. J. Anal. Toxicol., 25: 520-524.
30. Mucklow, J.C., Bending, M.R., Kahn, G.C., and Dollery, C.T. 1978. Drug concentration in saliva. Clin. Pharmacol. Ther., 24: 563-570.
31. Navazesh, M. 1993. Methods for collecting saliva. Ann. N. Y. Acad. Sci., 694: 72-77.
32. Niedbala, R.S., Kardos, K.W., and Fritch, D.F. 2001a. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J. Anal. Toxicol., 25: 289-303.
33. Niedbala, R.S., Kardos, K., and Waga, J. 2001b. Laboratory analysis of remotely collected oral fluid specimens for opiates by immunoassay. J. Anal. Toxicol., 25: 310-315.
34. O'Neal, C.L., Crouch, D.J., Rollins, D.E., and Fatah, A.A. 2000. The effects of collection methods on oral fluid codeine concentrations. J. Anal. Toxicol., 24: 536-542.
35. Ogert, R.A., Kusterbeck, A.W., Wemhoff, G.A., Burke, R., and Ligler, F.S. 1992. Detection of cocaine using flow immunosensors. Anal. Lett., 25: 1999-2019.
36. Peel, H.W., Perrigo, B.J., and Mikhael, N.Z. 1984. Detection of drugs in saliva of impaired drivers. J. Forensic Sci., 29: 185-189.
37. Samyn, N. and van Haeren, C. 2000. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int. J. Legal Med., 113: 150-154.
38. Thompson, L.K. and Cone, E.J. 1987. Determination of δ9- tetrahydrocannabinol in human blood and saliva by high-performance liquid chromatography with amperometric detection. J. Chromatogr. B. Biomed. Appl., 421: 91-97.
39. Townsend, S., Finlay, W.J.J., Hearty, S., and O'Kennedy, R. 2006. Optimizing recombinant antibody function in SPR immunosensing: The influence of antibody structural format and chip surface chemistry on assay sensitivity. Biosens. Bioelec., 22: 268-274.
40. Vining, R.F. and McGinley, R.A. 1987. The measurement of hormones in saliva: Possibilities and pitfalls. J. Steroid Biochem., 27: 81-94.
41. Wade, S.E. and Haegele, A.D. 1991. Time-integrated measurement of corticosteroids in saliva by oral diffusion sink technology. Clin. Chem., 37: 1166-1172.
42. Wan, S.H., Matin, S.B., and Azarnoff, D.L. 1978. Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH. Clin. Pharmacol. Ther., 23: 585-590.
43. Wish, E.D., Hoffman, J.A., and Nemes, S. 1997. The validity of self-reports of drug use at treatment admission and at followup: Comparisons with urinalysis and hair assays. NIDA Res. Monogr., 167: 200-226.
44. Yacoubian, G.S. Jr. 2000. A typology of St. Louis arrestees surveyed through the arrestee drug abuse monitoring (ADAM) program. J. Drug Educ., 30: 247-264.
45. Yacoubian, G.S. Jr., Wish, E.D., and Perez, D.M. 2001. A comparison of saliva testing to urinalysis in an arrestee population. J. Psychoactive Drugs, 33: 289-294.
46. Yacoubian, G.S. Jr., Wish, E.D., and Choyka, J.D. 2002. A comparison of the OnTrak Testcup-5 to laboratory urinalysis among arrestees. J. Psychoactive Drugs, 34: 325-329.